| JOURNAL HOME | CME HOME | THIS MONTH | PAST ISSUES | ETOC | COLLECTIONS |
| AUTHORS | REVIEWERS | EDITORIAL BOARD | FEEDBACK | RSS | HELP |
| ||||||||||||||
| ||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
Department of Anesthesia, Northwestern University Medical School, Chicago, Illinois
Abstract
Dose requirements for thiopental anesthetic induction have significant age- and gender-related variability. We studied the association of the patient characteristics age, gender, weight, lean body mass, and cardiac output with thiopental requirements. Doses of thiopental, infused at 150 mg/min, required to reach both a clinical end-point and an electroencephalographic (EEG) end-point were determined in 30 males and 30 females, aged 18--83 yr. Univariate least squares linear regression analysis revealed outliers in the relationships of age, weight, lean body mass, and cardiac output to thiopental dose at clinical and EEG endpoints. Differential weighting of data points minimized the effect of outliers in the construction of a robust multiple linear regression model of the relationship between several selected independent variables and the dependent variables thiopental dose at clinical and EEG endpoints. The multiple linear regression model for thiopental dose at the clinical end-point selecting the regressor variables age, weight, and gender (R2 = 0.76) was similar to that for age, lean body mass, and gender (R2 = 0.75). Thiopental dose at the EEG end-point was better described by models selecting the variables age, weight, and cardiac output (R2 = 0.88) or age, lean body mass, and cardiac output (R2 = 0.87). Although cardiac output varied with age, age always remained a selected variable. Because weight and lean body mass differed with gender, their selection as variables in the model eliminated gender as a selected variable or minimized its importance.
This article has been cited by other articles:
|
|
 |
|
  M. J. Avram, T. C. Krejcie, T. K. Henthorn, and C. U. Niemann {beta}-Adrenergic Blockade Affects Initial Drug Distribution Due to Decreased Cardiac Output and Altered Blood Flow Distribution J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 617 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Erhan, G. Ugur, I. Gunusen, I. Alper, and B. Ozyar Propofol - not thiopental or etomidate - with remifentanil provides adequate intubating conditions in the absence of neuromuscular blockade: [Le propofol, mais non le thiopental ou l'etomidate, combine au remifentanil, permet des conditions d'intubation satisfaisantes en l'absence de blocage neuromusculaire] Can J Anesth, February 1, 2003; 50(2): 108 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Thompson and G. B. Drummond Loss of volition and pain response during induction of anaesthesia with propofol or sevoflurane Br. J. Anaesth., August 1, 2001; 87(2): 283 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Strickland and G. B. Drummond* Comparison of pattern of breathing with other measures of induction of anaesthesia, using propofol, methohexital, and sevoflurane{{dagger}} Br. J. Anaesth., May 1, 2001; 86(5): 639 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. H.G. Wilder-Smith, P. A. Ravussin, L. A. Decosterd, P. A. Despland, and B. Bissonnette Midazolam premedication reduces propofol dose requirements for multiple anesthetic endpoints Can J Anesth, May 1, 2001; 48(5): 439 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. U. Adachi, K. Watanabe, H. Higuchi, and T. Satoh The Determinants of Propofol Induction of Anesthesia Dose Anesth. Analg., March 1, 2001; 92(3): 656 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Krejcie and M. J. Avram What Determines Anesthetic Induction Dose? It's the Front-End Kinetics, Doctor! Anesth. Analg., September 1, 1999; 89(3): 541 - 541. [Full Text] [PDF]
|
|
|
